Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-27

Clinical Trial Update: Anti-Mullerian Hormone as Predictor of Ovarian Responce to Clomiphene Citrate in PCOS [NA]

View source ↗

Summary

A clinical trial from Ain Shams University investigates whether anti-Müllerian hormone can predict ovarian response to clomiphene citrate in Polycystic Ovary Sy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOMIPHENE CITRATE (CLOMIPHENE CITRTAE)

Snippet

Sponsor: Ain Shams University | Conditions: Polycystic Ovary Syndrome | NA | Status: UNKNOWN